Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diabetic macular oedema: intravitreal bevacizumab versus conventional laser therapy
2007-000847-89Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Mar 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of bevacizumab in diabetic macular edema (DME) (2 arms), sponsored by Moorfields Eye Hospital. Primary endpoint: Mean ETDRS BCVA at 12 months. Started Mar 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2007-000847-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000847-89.